Nebu-Flow

Misti

Misti develops customisable nebuliser technology to deliver medicines to the lungs of children and older adults with respiratory diseases.

Activaero

The company develops controlled breathing systems and smart nebulisers to deliver inhaled drugs for patients with severe respiratory diseases.

Softhale

This company develops propellant-free soft mist inhaler devices and pharmaceutical products for patients suffering from asthma and chronic obstructive pulmonary disease.

AQUILON PHARMACEUTICALS

The company develops inhaled medicines and nasal sprays for patients with asthma, chronic obstructive pulmonary disease and other respiratory conditions.

Aflo Analytics

This company develops a digital platform and connected sensor that monitors inhaler technique and adherence for patients with respiratory conditions and their clinicians.

Pneumagen

This clinical-stage biotech company develops intranasal antiviral drugs to prevent and treat respiratory tract infections for patients with chronic lung diseases.

Respira

This biopharmaceutical company develops inhaled drug-device therapies for patients with cardiopulmonary diseases such as pulmonary hypertension and interstitial lung disease.

Kither Biotech

This company develops inhaled therapies for patients with respiratory diseases such as chronic obstructive pulmonary disease and cystic fibrosis.